A phase 1b/2, study of nivolumab following preoperative chemoradiotherapy in patients with resectable rectal cancer

Category Primary study
JournalCancer Science
Year 2018
This article has no abstract
Epistemonikos ID: dca215b9b47c964c2ea12601c851eea4624bc182
First added on: Feb 09, 2025